Esperion Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 17.68 M | $65.42 M | 19.20% | 8.92% |
| VANGUARD GROUP INC | 01/29/2026 | 14.95 M | $55.30 M | 23.59% | 7.54% |
| TWO SEAS CAPITAL LP | 02/11/2026 | 11.90 M | $44.04 M | 22.08% | 6.01% |
| WASATCH ADVISORS LP | 02/12/2026 | 9.45 M | $34.95 M | 33.76% | 4.77% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 6.90 M | $25.54 M | 3,208.91% | 3.48% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 5.97 M | $22.07 M | 100.00% | 3.01% |
| STATE STREET CORP | 02/13/2026 | 5.93 M | $21.94 M | 32.41% | 2.99% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 5.74 M | $21.23 M | 20.76% | 2.90% |
| MARSHALL WACE, LLP | 02/13/2026 | 5.47 M | $20.24 M | 117.00% | 2.76% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 4.74 M | $17.55 M | 111.83% | 2.39% |
| PENDERFUND CAPITAL MANAGEMENT LTD. | 02/17/2026 | 4.39 M | $16.25 M | -34.22% | 2.22% |
| AIGH CAPITAL MANAGEMENT LLC | 02/02/2026 | 4.00 M | $14.80 M | 33.33% | 2.02% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 3.93 M | $14.55 M | 303.37% | 1.98% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 3.85 M | $14.25 M | 100.00% | 1.94% |
| NUVEEN, LLC | 02/12/2026 | 3.61 M | $13.36 M | -2.67% | 1.82% |
| ROYCE & ASSOCIATES LP | 02/09/2026 | 3.60 M | $13.33 M | 57.03% | 1.82% |
| MORGAN STANLEY | 02/13/2026 | 3.51 M | $13.00 M | -13.35% | 1.77% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 3.51 M | $12.97 M | 83.71% | 1.77% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 2.85 M | $10.54 M | 66.68% | 1.44% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 2.19 M | $8.12 M | 183.58% | 1.11% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 2.14 M | $7.93 M | 100.00% | 1.08% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 2.09 M | $7.75 M | 167,721.47% | 1.06% |
| NORTHERN TRUST CORP | 02/17/2026 | 2.00 M | $7.38 M | 7.97% | 1.01% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 1.57 M | $5.81 M | 391.62% | 0.79% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/13/2026 | 1.21 M | $4.48 M | 100.00% | 0.61% |
| VOLEON CAPITAL MANAGEMENT LP | 02/17/2026 | 1.15 M | $4.27 M | 455.32% | 0.58% |
| JANE STREET GROUP, LLC | 02/12/2026 | 1.08 M | $4.00 M | -44.66% | 0.55% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 1.07 M | $3.97 M | 805.42% | 0.54% |
| JPMORGAN CHASE & CO | 02/11/2026 | 965.06 K | $3.57 M | 2.07% | 0.49% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 935.92 K | $3.46 M | -1.94% | 0.47% |
| JANE STREET GROUP, LLC | 02/12/2026 | 803.10 K | $2.97 M | 481.96% | 0.41% |
| INVESCO LTD. | 02/19/2026 | 765.12 K | $2.83 M | 23.45% | 0.39% |
| CITADEL ADVISORS LLC | 02/17/2026 | 750.10 K | $2.78 M | -50.99% | 0.38% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 715.33 K | $2.65 M | 21.98% | 0.36% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 696.79 K | $2.58 M | 128.78% | 0.35% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 641.18 K | $2.37 M | -5.89% | 0.32% |
| VICTORY CAPITAL MANAGEMENT INC | 02/13/2026 | 595.98 K | $2.21 M | 39.62% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 549.09 K | $2.03 M | 18.57% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 540.80 K | $2.00 M | 111.09% | 0.27% |
| BARCLAYS PLC | 02/13/2026 | 443.34 K | $1.64 M | 32.10% | 0.22% |
| CITADEL ADVISORS LLC | 02/17/2026 | 412.80 K | $1.53 M | -2.39% | 0.21% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 02/17/2026 | 400.00 K | $1.48 M | 100.00% | 0.20% |
| CITADEL ADVISORS LLC | 02/17/2026 | 351.70 K | $1.30 M | 310.86% | 0.18% |
| SUMMIT WEALTH GROUP, LLC | 02/06/2026 | 340.61 K | $1.26 M | 5.45% | 0.17% |
| MACKENZIE FINANCIAL CORP | 02/18/2026 | 336.99 K | $1.24 M | 23.46% | 0.17% |
| UBS GROUP AG | 01/29/2026 | 313.35 K | $1.16 M | -74.86% | 0.16% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 290.51 K | $1.07 M | 1.97% | 0.15% |
| MARINER, LLC | 02/13/2026 | 278.66 K | $1.03 M | -7.88% | 0.14% |
| PRINCIPAL FINANCIAL GROUP INC | 02/02/2026 | 276.29 K | $1.02 M | 45.37% | 0.14% |
| RHUMBLINE ADVISERS | 02/13/2026 | 269.74 K | $998.02 K | -2.79% | 0.14% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Esperion Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 308 institutional investors and hedge funds held shares of Esperion Therapeutics Inc.. The most heavily invested institutionals were:
WASATCH ADVISORS LP: 15.77 M
AIGH Capital Management LLC: 4.4 M
UBS Group AG: 4.29 M
Nuveen, LLC: 3.61 M
Privium Fund Management B.V.: 3.3 M
ROYCE & ASSOCIATES LP: 2.63 M
76.34% of Esperion Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 193.45 M shares in the last 24 months. This purchase volume represents approximately $588.08 M in transactions.